Compare RNTX & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNTX | ZDGE |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | 10 | 55 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 39.9M |
| IPO Year | N/A | 2016 |
| Metric | RNTX | ZDGE |
|---|---|---|
| Price | $1.02 | $3.14 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 841.5K | 64.6K |
| Earning Date | 05-15-2026 | 06-11-2026 |
| Dividend Yield | N/A | ★ 1.96% |
| EPS Growth | N/A | ★ 73.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,398,000.00 |
| Revenue This Year | N/A | $3.27 |
| Revenue Next Year | N/A | $5.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $2.21 |
| 52 Week High | $2.18 | $4.70 |
| Indicator | RNTX | ZDGE |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 54.60 |
| Support Level | N/A | $2.89 |
| Resistance Level | $1.33 | $3.43 |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 24.94 | 84.29 |
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.